Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
03/2010
03/23/2010US7682611 Chemokine receptor-4 (CXCR4) specific immunoglobulin for diagnosis, prevention and treatment of viral or bacterial infection
03/23/2010US7682610 Vascular endothelial growth factor receptor specific immunoglobulin for diagnosis, prevention and treatment of cell proliferative disorders
03/23/2010CA2389808C Antibodies to bis[sulfosuccinimidyl] suberate (bs3) or disuccinimidyl suberate (dss) as labels for proteins and nucleic acids
03/23/2010CA2305312C Mammalian genes involved in viral infection and tumor suppression
03/23/2010CA2283535C Glycine transporter
03/23/2010CA2236168C Disruption of expression of multiple alleles of mammalian genes
03/23/2010CA2223412C Method for prolonging the expression of a gene of interest using soluble ctla4 molecules
03/23/2010CA2209124C Antitumor agent effect enhancer containing il-6 antagonist
03/23/2010CA2203655C Tumor necrosis factor-gamma
03/18/2010WO2010030999A1 Sweetener preparations and methods of use
03/18/2010WO2010029685A1 Method for designing mutant enzyme, method for preparing mutant enzyme, and mutant enzyme
03/18/2010WO2009158627A3 Cellulosic protein expression in yeast
03/18/2010WO2009151491A3 In vivo incorporation of an unnatural amino acid comprising a 1,2-aminothiol group
03/18/2010WO2009140670A9 Methods for assessing colorectal cancer and compositions for use therein
03/18/2010WO2009137934A4 Oilseed protein concentrates and isolates, and processes for the production thereof
03/18/2010WO2009137758A3 Igf-ii/gf-iie binding proteins
03/18/2010WO2009131605A3 Fusion partner cell line for preparation of hybrid cells expressing human antibodies
03/18/2010WO2009126920A3 Human serum albumin linkers and conjugates thereof
03/18/2010WO2009051846A3 Translocation and mutant ros kinase in human non-small cell lung carcinoma
03/18/2010US20100071080 Antibodies to sulfated carbohydrates
03/18/2010US20100069611 Cytolethal distending toxins and detection of campylobacter bacteria using the same as a target
03/18/2010US20100069300 C-Type Lectin Fold as a Scaffold for Massive Sequence Variation
03/18/2010US20100069262 Method for Cloning Avian-Derived Antibodies
03/18/2010US20100068763 Mammalian chemokines; receptors; reagents; uses
03/18/2010US20100068762 Novel nucleic acid molecules
03/18/2010US20100068761 Isolation and characterization of a novel pythium omega 3 desaturase with specificity to all omega 6 fatty acids longer than 18 carbon chains
03/18/2010US20100068760 Proteins with esterase activity
03/18/2010US20100068759 Modified chondroitin synthase polypeptide and crystal thereof
03/18/2010US20100068758 Mutant arabinose promoter for inducible gene expression
03/18/2010US20100068728 Polysaccharide derivatives and uses in induction of an immune response
03/18/2010US20100068335 Phytases with improved thermal stability
03/18/2010US20100068229 Recombinant antigens of human cytomegalovirus (hcmv)
03/18/2010US20100068220 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby
03/18/2010US20100064746 Involves transport of further-treated fermented biomass from one location to another, such as by ship, truck or plane to be further fermented and form another energy product, such as ethanol, butanol, biodiesel, biogasoline, hydrogen, electricity, chemicals
03/18/2010CA2736498A1 Compositions and methods for purifying calreticulin
03/17/2010EP2163643A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
03/17/2010EP2163642A1 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis
03/17/2010EP2163640A1 Recombinant protein production in a human cell comprising at least one E1 protein of adenovirus
03/17/2010EP2163626A1 Human FGF-21 gene and gene expression products
03/17/2010EP2163561A1 NOGO receptor-mediated blockade of axonal growth
03/17/2010EP2163256A1 Specific binding proteins and uses thereof
03/17/2010EP1664300B1 A new class of a2delta calcium channel subunits
03/17/2010EP1303536B1 Novel fibroblast growth factor (fgf23) and methods for use
03/17/2010EP1301078B1 Peroxide treated yeast extract and method of production
03/17/2010CN101675160A Use of protein hydrolysates to stabilize metalloprotease detergent formulations
03/17/2010CN101675158A Cancerous disease modifying antibodies
03/17/2010CN101671713A Kringle 5 gene-containing engineered bacterium fermentation process and kringle 5 protein purification process
03/17/2010CN101671689A Recombinant expression carrier containing schistosoma japonicum gene and application thereof
03/17/2010CN101671688A Beta 2 adrenergic receptor fused with EGFP, recombination expression carrier and constructing method thereof
03/17/2010CN101671394A Antibody of anti hAPE1 protein and preparation method thereof as well as kit applying antibody
03/17/2010CN101671393A Angiopoietin-2 specific binding agents
03/17/2010CN101671392A Monoclonal antibody resisting hemocyanin of China prawns as well as preparation method and application thereof
03/17/2010CN100594036C Animal medicine capable of rehabilitating intestinal tract injury
03/16/2010US7678887 Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade
03/16/2010US7678885 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
03/16/2010US7678569 Cloned genome of infectious hepatitis C virus strain HC-TN and uses thereof
03/16/2010US7678558 Method for overexpression of zwitterionic polysaccharides
03/16/2010US7678553 Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
03/16/2010CA2423616C Chemokine mutants in the treatment of multiple sclerosis
03/16/2010CA2422216C Method for the production of vitamin k-dependent proteins
03/16/2010CA2296766C Aggrecan degrading metallo proteases
03/16/2010CA2200054C Use of antibodies to block the effects of gram-positive bacteria and mycobacteria
03/11/2010WO2010028245A2 Altered phic31 integrases having improved efficiency and specificity and methods of using same
03/11/2010WO2010027370A1 Compositions and methods for the treatment of solid tumor cancers
03/11/2010WO2010027062A1 B cell-derived ips cells and application thereof
03/11/2010WO2010026758A1 Monoclonal antibody, and immunoassay using same
03/11/2010WO2010025541A1 Identification of a conserved inner core oligosaccharide region of moraxella catarrhalis lipopolysaccharide as a vaccine antigen
03/11/2010US20100064393 Bacillus liceniformis chromosome
03/11/2010US20100063260 Whitefly Ecdysone Receptor Antibody
03/11/2010US20100063130 Method for promoting immune response comprising inhibiting cd22 function in b cells
03/11/2010US20100062982 Avian derived fusion proteins
03/11/2010US20100062973 Production of bioactive glycoproteins from inactive starting material
03/11/2010US20100062950 Constructs and libraries comprising antibody surrogate kappa light chain sequences
03/11/2010US20100062523 Expression of Class 2 Mannosidase and Class III Mannosidase in Lower Eukaryotic Cells
03/11/2010US20100062516 Expression of Class 2 Mannosidase and Class III Mannosidase in Lower Eukaryotic Cells
03/11/2010US20100062514 Rearranged squamous cell carcinoma antigen genes ii
03/11/2010US20100062491 Overexpression of the Chaperone BIP in a Heterokaryon
03/11/2010US20100062490 Organic Compounds
03/11/2010US20100062489 Duck embryonic derived stem cell lines for the production of viral vaccines
03/11/2010US20100062488 Preparation process of recombinant human p43 protein
03/11/2010US20100062487 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
03/11/2010US20100062486 Novel protein and dna encoding the protein
03/11/2010US20100062485 Novel Hansenula Polymorpha Gene Coding for Dolichyl-Phosphate- Mannose Dependent Alpha-1,3 Mannosyltransferase and Process for the Production of Recombinant Glycoproteins With Hansenula Polymorpha Mutant Strain Deficient in
03/11/2010US20100062484 Recombinant n-glycosylated proteins from procaryotic cells
03/11/2010US20100062477 Methods of isolating and propagating stem cells from benign tumors
03/11/2010US20100062451 Bead-ligand-nascent protein complexes
03/11/2010US20100062028 Vaccines for malaria
03/11/2010US20100062015 Fusion protein vaccine
03/11/2010US20100062013 Cancer antigen peptides derived from wt1
03/11/2010US20100062009 for cancer, immune, infectious and ischemic diseases; inhibiting tumor growth; allergy
03/11/2010US20100062008 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
03/11/2010US20100062004 Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
03/11/2010US20100061961 Recombinant super-compound interferon
03/11/2010CA2734704A1 Monoclonal antibody and immunoassay using the same
03/11/2010CA2732338A1 Identification of a conserved inner core oligosaccharide region of moraxella catarrhalis lipopolysaccharide as a vaccine antigen
03/10/2010EP2161338A1 Isolated mammalian monocyte cell genes; related reagents
03/10/2010EP2161336A1 Human monoclonal antibodies to programmed death 1(PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
03/10/2010EP2161335A1 NOVEL GPIIIa GENE
03/10/2010EP2161286A1 Antibodies
03/10/2010EP2161281A1 Muteins of fibroblast growth factor 21
1 ... 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 ... 1125